Correlation Between Cue Biopharma and INmune Bio
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and INmune Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and INmune Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and INmune Bio, you can compare the effects of market volatilities on Cue Biopharma and INmune Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of INmune Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and INmune Bio.
Diversification Opportunities for Cue Biopharma and INmune Bio
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cue and INmune is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and INmune Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INmune Bio and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with INmune Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INmune Bio has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and INmune Bio go up and down completely randomly.
Pair Corralation between Cue Biopharma and INmune Bio
Considering the 90-day investment horizon Cue Biopharma is expected to under-perform the INmune Bio. In addition to that, Cue Biopharma is 2.0 times more volatile than INmune Bio. It trades about -0.26 of its total potential returns per unit of risk. INmune Bio is currently generating about -0.27 per unit of volatility. If you would invest 617.00 in INmune Bio on August 29, 2024 and sell it today you would lose (129.00) from holding INmune Bio or give up 20.91% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Cue Biopharma vs. INmune Bio
Performance |
Timeline |
Cue Biopharma |
INmune Bio |
Cue Biopharma and INmune Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cue Biopharma and INmune Bio
The main advantage of trading using opposite Cue Biopharma and INmune Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, INmune Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INmune Bio will offset losses from the drop in INmune Bio's long position.Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
INmune Bio vs. Tff Pharmaceuticals | INmune Bio vs. Anebulo Pharmaceuticals | INmune Bio vs. AN2 Therapeutics | INmune Bio vs. Cue Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Stocks Directory Find actively traded stocks across global markets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |